Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial.
Lins, Robert L; Elseviers, Monique M; Van der Niepen, Patriciaet al.
2009 • In Nephrology Dialysis Transplantation, 24 (2), p. 512-8
[en] BACKGROUND: There is uncertainty on the effect of different dialysis modalities for the treatment of patients with acute kidney injury (AKI), admitted to the intensive care unit (ICU). This controlled clinical trial performed in the framework of the multicentre SHARF 4 study (Stuivenberg Hospital Acute Renal Failure) aimed to investigate the outcome in patients with AKI, stratified according to severity of disease and randomized to different treatment options. METHODS: This was a multicentre prospective randomized controlled trial with stratification according to severity of disease expressed by the SHARF score. ICU patients were eligible for inclusion when serum creatinine was >2 mg/dL, and RRT was initiated. The selected patients were randomized to intermittent (IRRT) or continuous renal replacement therapy (CRRT). RESULTS: A total of 316 AKI patients were randomly assigned to IRRT (n = 144) or CRRT (n = 172). The mean age was 66 (range 18-96); 59% were male. Intention-to-treat analysis revealed a mortality of 62.5% in IRRT compared to 58.1% in CRRT (P = 0.430). No difference between IRRT and CRRT could be observed in the duration of ICU stay or hospital stay. In survivors, renal recovery at hospital discharge was comparable between both groups. Multivariate analysis, including the SHARF score, APACHE II and SOFA scores for correction of disease severity, showed no difference in mortality between both treatment modalities. This result was confirmed in pre-specified subgroup analysis (elderly, patients with sepsis, heart failure, ventilation) and after exclusion of possible confounders (early mortality, delayed ICU admission). CONCLUSIONS: Modality of RRT, either CRRT or IRRT, had no impact on the outcome in ICU patients with AKI. Both modalities need to be considered as complementary in the treatment of AKI (Clinical Trial: SHARF 4, NCT00322933, http://ClinicalTrials.gov).
Disciplines :
Urology & nephrology Anesthesia & intensive care
Author, co-author :
Lins, Robert L
Elseviers, Monique M
Van der Niepen, Patricia
Hoste, Eric
Malbrain, Manu L
Damas, Pierre ; Université de Liège - ULiège > Département des sciences cliniques > Anesthésie et réanimation
Devriendt, Jacques
Language :
English
Title :
Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial.
Mehta RL, Letteri JM. Current status of renal replacement therapy for acute renal failure. Am J Nephrol 1999; 19: 377-382.
Ympa YP, Sakr Y, Reinhart K et al. Has mortality from acute renal failure decreased? A systematic review of the literature. Am J Med 2005; 118: 827-832.
Feest TG, Round A, Hamad S. Incidence of severe acute renal failure in adults: results of a community based study. BMJ 1993; 306: 481-483.
Chew SL, Lins RL, Daelemans R et al. Outcome in acute renal failure. Nephrol Dial Transplant 1993; 8: 101-107
Lins RL, ChewSL, Daelemans R. Epidemiology of acute renal failure. In:Bellomo R, RoncoC(eds). Acute Renal Failure in theClinically Ill. Epidemiology of Acute Renal Failure, Vol. 20. Heidelberg: Springer, 1994, 148-159
Liano F, Pascual J, Madrid Acute Renal Failure Study Group. Epidemiology of acute renal failure: a prospective, multicentre, community-based study. Kidney Int 1996; 50: 811-818
Schwartz RD, Messana JM, Orzol S et al. Comparing continuous hemofiltration with hemodialysis in patients with severe acute renal failure. Am J Kidney Dis 1999; 34: 424-432
Kresse S, Schlee H, Deuber HJ et al. Influence of renal replacement therapy on outcome of patients with acute renal failure. Kidney Int 1999; 56: 75-78
Guérin C, Girard R, Selli JM et al. Intermittent versus continuous renal replacement therapy for acute renal failure in intensive care unit; results from a multicentre prospective epidemiological survey. Intensive Care Med 2002; 28: 1411-1418
Chang JW, Yang WS, Seo JW et al. Continuous venovenous hemodiafiltration versus hemodialysis as renal replacement therapy in patients with acute renal failure in the intensive care unit. Scand J Urol Nephrol 2004; 38: 417-421
Cho KC, Himmelfarb J, Paganini E et al. Survival by dialysis modality in critically ill patients with acute kidney injury. J Am Soc Nephrol 2006; 17: 3232-3138
Mehta R, Mcdonald B, Gabbai F et al. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001; 60: 1154-1163
Augustine JJ, Sandy D, Seifert TH et al. A randomised, controlled trial, comparing intermittent with continuous venovenous dialysis in patients with AKI. Am J Kidney Dis 2004;44:1000-1007
Uehlinger DE, Jakob SM, Ferrari P et al. Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant 2005; 20: 1630-1637
Vinsonneau C, Camus C, Comber A et al. for the Hemodiafe Study Group. Continuous venovenous haemofiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 2006; 368: 379-385
Tonelli M, Manns B, Feller-Kopman D. Acute renal failure in the intensive care unit: a systematic reviewof the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 2002; 40: 875-885
Kellum JA, Angus DC, Johnson JP et al. Continuous versus intermittent renal replacement therapy a meta-analysis. Intensive Care Med 2002; 28: 29-37
Pannu N, Klarenbach S, Wiebe N et al. Renal replacement therapy in patients with acute renal failure: a systematic review. JAMA 2008; 299: 793-805
Lins R, Elseviers M, Daelemans R et al. Prognostic value of a new scoring system for hospital mortality in acute renal failure. Clin Nephrol 2000; 53: 10-17
Lins RL, Elseviers MM, Daelemans R et al. Re-evaluation and modification of the Stuivenberg hospital acute renal failure (SHARF) scoring system for the prognosis of acute renal failure: an independent multicentre, prospective study. Nephrol Dial Transplant 2004; 19: 2282-2288
Knaus WA. Apache II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829
Vincent JL, Morenco R, Takala J et al. The SOFA (sepsis related organ failure assessment) score to describe organ dysfunction/failure. Int Care Med 1996; 22: 707-710
Jakob SM, Frey FJ, Uehlinger DE. Does continuous renal replacement therapy favourably influence the outcome of the patients? Nephrol Dial Transplant 1996; 11: 1250-1255
Lameire N, Van Biesen W, Vanholder R. Dialysing the patient with acute renal failure in the ICU: the emperor's clothes? Nephrol Dial Transplant 1999; 14: 2570-2573
Kanagasundaram NS, Paganini EP. Critical care dialysis: a gordian knot (but is untying the right approach?). Nephrol Dial Transplant 1999; 14: 2590-2594
Swartz RD, Bustami RT, Daley JM et al. Estimating the impact of renal replacement therapy choice on outcome in severe acute renal failure. Clin Nephrol 2005; 63: 335-345
Mehta RL, Pascual MT, Savage BR et al. Lower than expected mortality rates in critically ill patients with acute renal failure: PICARD study experience. J Am Soc Nephrol 2002; 13: 644A
Bell M, SWING, Granath F et al. Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure. Intensive Care Med 2007; 33: 773-780
Uchino S, Bellomo R, Kellum JA et al. Patient and kidney survival by dialysis modality in critically ill patients with acute kidney injury. Int J Artif Organs 2007; 30: 281-292
John S, Griesbach D, Baumgärtel M et al. Effects of continuous vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial. Nephrol Dial Transplant 2001; 16: 320-327
Saudan P, Niederberger M, De Seigneux S et al. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 2006; 70: 1312-1317
Lins RL, Elseviers MM, Van der Niepen P et al. Influence of dialysis dose on outcome in AKI patients: results of SHARF 4 study. Abstracts of the ASN Renal week 2005, 8-13 November 2005, Philadelphia, USA
The VA/NIH Acute Renal Failure Trial Network. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359: 7-20
Van Berendoncks A, Elseviers MM, Lins RL. Outcome of acute renal failure with different treatment modalities: long term follow-up. Abstracts of the 43rd congress of the ERA-EDTA, 15-18 July 2006, Glasgow, UK
Lins RL, Elseviers MM, Van Der Niepen P et al. Long-term cost analysis of AKI in patients admitted to the ICU. Abstracts of the ASN Renal week 2006, 14-19 November 2006, San Diego, USA
